These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21678305)

  • 1. [Clinical significance of interactions between clopidogrel and proton pump inhibitors].
    Kubica A; Koziński M; Grześk G; Goch A
    Kardiol Pol; 2011; 69(6):610-6. PubMed ID: 21678305
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction between clopidogrel and proton pump inhibitors: hypothesis to explain multifactorial CYP2C19 inhibition.
    Zhang H; Ragueneau-Majlessi I; Levy RH
    Drug Metab Lett; 2009 Dec; 3(4):287-9. PubMed ID: 19995331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPI interactions with clopidogrel revisited.
    Med Lett Drugs Ther; 2009 Feb; 51(1306):13-4. PubMed ID: 19229161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In brief: Clopidogrel and omeprazole.
    Med Lett Drugs Ther; 2010 Nov; 52(1352):93. PubMed ID: 21166090
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clopidogrel and proton pump inhibitors: insufficient evidence of interaction].
    Hunfeld NG; Valkhoff VE; Touw DJ; Sturkenboom MC; Kuipers EJ
    Ned Tijdschr Geneeskd; 2011; 155(28):A2404. PubMed ID: 21771376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes.
    Furuta T; Iwaki T; Umemura K
    Br J Clin Pharmacol; 2010 Sep; 70(3):383-92. PubMed ID: 20716239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of proton pump inhibitor omeprazole on the antiplatelet effect of clopidogrel in individuals with various CYP2C19*2 genotypes].
    Lu FM; Tong ZL; Mao YM; Wu DY; Xu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):478-81. PubMed ID: 22875511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2C19 genotype and proton pump inhibitors in clopidogrel-treated patients: does it take two to tango?
    O'Donoghue ML
    Circulation; 2011 Feb; 123(5):468-70. PubMed ID: 21262991
    [No Abstract]   [Full Text] [Related]  

  • 9. Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations.
    Ellis KJ; Stouffer GA; McLeod HL; Lee CR
    Pharmacogenomics; 2009 Nov; 10(11):1799-817. PubMed ID: 19891556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does CYP2C19 inhibition lead to clopidogrel thrombogenicity?
    Cohen MJ
    Med Hypotheses; 2011 Sep; 77(3):448-50. PubMed ID: 21719206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinically relevant interaction between clopidogrel and proton pump inhibitors].
    Alban S; Dingermann T; Griese N; Kämmerer W; Schubert-Zsilavecz M; Schulz M; Trenk D; Zagermann-Muncke P
    Pharm Unserer Zeit; 2009; 38(4):370-1. PubMed ID: 19572357
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-drug interaction between clopidogrel and the proton pump inhibitors.
    Norgard NB; Mathews KD; Wall GC
    Ann Pharmacother; 2009 Jul; 43(7):1266-74. PubMed ID: 19470853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors and clopidogrel.
    Gaglia MA; Waksman R
    Cardiovasc Ther; 2010 Jun; 28(3):169-76. PubMed ID: 20345494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Should we believe in the interaction between proton pump inhibitors (PPI) and clopidogrel].
    Besse V; Gerstel E
    Rev Med Suisse; 2010 Oct; 6(267):1970, 1972-5. PubMed ID: 21125730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C19 genetic polymorphism, rabeprazole and esomeprazole have no effect on the antiplatelet action of clopidogrel.
    El-Halabi MM; Zgheib N; Mansour NM; Malli A; Ghaith OA; Mahfouz R; Alam S; Sharara AI
    J Cardiovasc Pharmacol; 2013 Jul; 62(1):41-9. PubMed ID: 23474843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risky to combine clopidogrel with proton pump inhibitor?].
    Wall U; Andrén L
    Lakartidningen; 2009 Dec; 106(52):3523-4. PubMed ID: 20151516
    [No Abstract]   [Full Text] [Related]  

  • 17. What's new about clopidogrel.
    Cialdella P; Gustapane M; Camaioni C; Biasucci LM
    Minerva Cardioangiol; 2013 Dec; 61(6):683-9. PubMed ID: 24253460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies.
    Angiolillo DJ; Gibson CM; Cheng S; Ollier C; Nicolas O; Bergougnan L; Perrin L; LaCreta FP; Hurbin F; Dubar M
    Clin Pharmacol Ther; 2011 Jan; 89(1):65-74. PubMed ID: 20844485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic evaluation of pantoprazole therapy on clopidogrel effects: results of a prospective, randomized, crossover study.
    Ferreiro JL; Ueno M; Tomasello SD; Capodanno D; Desai B; Dharmashankar K; Seecheran N; Kodali MK; Darlington A; Pham JP; Tello-Montoliu A; Charlton RK; Bass TA; Angiolillo DJ
    Circ Cardiovasc Interv; 2011 Jun; 4(3):273-9. PubMed ID: 21521834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.
    Gurbel PA; Lau WC; Tantry US
    J Am Coll Cardiol; 2008 Jan; 51(3):261-3. PubMed ID: 18206733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.